The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Major findings and recent advances in virus–like particle (VLP)-based vaccines
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Self-citationPeptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
Zakeri, B., Fierer, J. O., Celik, E., Chittock, E. C., Schwarz-Linek, U., Moy, V. T., & Howarth, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115485109 · Cited by 1,662
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Self-citationTherapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast
Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., & Hall, B. D. (1982) · Nature · doi:10.1038/298347a0 · Cited by 877
N-Linked Glycosylation in Campylobacter jejuni and Its Functional Transfer into E. coli
Wacker, M., Linton, D., Hitchen, P. G., Nita-Lazar, M., Haslam, S. M., North, S. J., Panico, M., Morris, H. R., Dell, A., Wren, B. W., et al. (2002) · Science · doi:10.1126/science.298.5599.1790 · Cited by 777
A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
The RTS, S. C. T. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208394 · Cited by 752
The Influence of Antigen Organization on B Cell Responsiveness
Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · Science · doi:10.1126/science.8248784 · Cited by 717
Self-citationCarrasco, Y. R., & Batista, F. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.007 · Cited by 617
Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., & Rock, K. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4942 · Cited by 591
Kushnir, N., Streatfield, S. J., & Yusibov, V. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.083 · Cited by 587
Wykes, M., Pombo, A., Jenkins, C., & MacPherson, G. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1313 · Cited by 462
HPV vaccines – A review of the first decade
Harper, D. M., & DeMars, L. R. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.04.004 · Cited by 429
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
Brune, K. D., Leneghan, D. B., Brian, I. J., Ishizuka, A. S., Bachmann, M. F., Draper, S. J., Biswas, S., & Howarth, M. (2016) · Scientific Reports · doi:10.1038/srep19234 · Cited by 412
Self-citationHarding, C. V., & Song, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.4925 · Cited by 383
The coming of age of virus-like particle vaccines
Jennings, G. T., & Bachmann, M. F. (2008) · bchm · doi:10.1515/bc.2008.064 · Cited by 369
Self-citationCell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like Particles
Ashley, C. E., Carnes, E. C., Phillips, G. K., Durfee, P. N., Buley, M. D., Lino, C. A., Padilla, D. P., Phillips, B., Carter, M. B., Willman, C. L., et al. (2011) · ACS Nano · doi:10.1021/nn201397z · Cited by 350
Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery
Rohovie, M. J., Nagasawa, M., & Swartz, J. R. (2017) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10049 · Cited by 340
Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
Chan, H. L.-Y., Thompson, A., Martinot-Peignoux, M., Piratvisuth, T., Cornberg, M., Brunetto, M. R., Tillmann, H. L., Kao, J.-H., Jia, J.-D., Wedemeyer, H., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.006 · Cited by 321
Winblad, B., Andreasen, N., Minthon, L., Floesser, A., Imbert, G., Dumortier, T., Maguire, R. P., Blennow, K., Lundmark, J., Staufenbiel, M., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70140-0 · Cited by 310
Bright, R. A., Carter, D. M., Daniluk, S., Toapanta, F. R., Ahmad, A., Gavrilov, V., Massare, M., Pushko, P., Mytle, N., Rowe, T., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.106 · Cited by 288
Storni, T., Ruedl, C., Schwarz, K., Schwendener, R. A., Renner, W. A., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1777 · Cited by 286
Self-citationTissot, A. C., Maurer, P., Nussberger, J., Sabat, R., Pfister, T., Ignatenko, S., Volk, H.-D., Stocker, H., Müller, P., Jennings, G. T., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60381-5 · Cited by 286
Self-citationA vaccine against nicotine for smoking cessation: a randomized controlled trial
Cornuz, J., Zwahlen, S., Jungi, W. F., Osterwalder, J., Klingler, K., van Melle, G., Bangala, Y., Guessous, I., Müller, P., Willers, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002547 · Cited by 281
Maurer, P., Jennings, G. T., Willers, J., Rohner, F., Lindman, Y., Roubicek, K., Renner, W. A., Müller, P., & Bachmann, M. F. (2005) · European Journal of Immunology · doi:10.1002/eji.200526285 · Cited by 279
TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a
Jegerlehner, A., Maurer, P., Bessa, J., Hinton, H. J., Kopf, M., & Bachmann, M. F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2415 · Cited by 273
Self-citationThe Role of Antibody Concentration and Avidity in Antiviral Protection
Bachmann, M. F., Kalinke, U., Althage, A., Freer, G., Burkhart, C., Roost, H.-P., Aguet, M., Hengartner, H., & Zinkernagel, R. M. (1997) · Science · doi:10.1126/science.276.5321.2024 · Cited by 267
Self-citationCho, H. J., Takabayashi, K., Cheng, P.-M., Nguyen, M.-D., Corr, M., Tuck, S., & Raz, E. (2000) · Nature Biotechnology · doi:10.1038/75365 · Cited by 258
Chang, L.-J., Dowd, K. A., Mendoza, F. H., Saunders, J. G., Sitar, S., Plummer, S. H., Yamshchikov, G., Sarwar, U. N., Hu, Z., Enama, M. E., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61185-5 · Cited by 257
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
Collins, K. A., Snaith, R., Cottingham, M. G., Gilbert, S. C., & Hill, A. V. S. (2017) · Scientific Reports · doi:10.1038/srep46621 · Cited by 253
Chackerian, B., Lowy, D. R., & Schiller, J. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11849 · Cited by 251
El‐Kamary, S. S., Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R., Richardson, C., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/657087 · Cited by 226
Senti, G., Johansen, P., Haug, S., Bull, C., Gottschaller, C., Müller, P., Pfister, T., Maurer, P., Bachmann, M. F., Graf, N., et al. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03191.x · Cited by 219
Self-citationAmbühl, P. M., Tissot, A. C., Fulurija, A., Maurer, P., Nussberger, J., Sabat, R., Nief, V., Schellekens, C., Sladko, K., Roubicek, K., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32800ff5d6 · Cited by 219
Self-citationGoldinger, S. M., Dummer, R., Baumgaertner, P., Mihic‐Probst, D., Schwarz, K., Hammann‐Haenni, A., Willers, J., Geldhof, C., Prior, J. O., Kündig, T. M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142361 · Cited by 201
Self-citationDer p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Kündig, T. M., Senti, G., Schnetzler, G., Wolf, C., Prinz Vavricka, B. M., Fulurija, A., Hennecke, F., Sladko, K., Jennings, G. T., & Bachmann, M. F. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.040 · Cited by 199
Self-citationPlant-derived virus-like particles as vaccines
Chen, Q., & Lai, H. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22218 · Cited by 183
Role of Toll‐like receptors in costimulating cytotoxic T cell responses
Schwarz, K., Storni, T., Manolova, V., Didierlaurent, A. M., Sirard, J., Röthlisberger, P., & Bachmann, M. F. (2003) · European Journal of Immunology · doi:10.1002/eji.200323919 · Cited by 171
Self-citationThe novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma
Beeh, K.-M., Kanniess, F., Wagner, F., Schilder, C., Naudts, I., Hammann-Haenni, A., Willers, J., Stocker, H., Mueller, P., Bachmann, M. F., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1561 · Cited by 168
Self-citationLong-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
Farlow, M. R., Andreasen, N., Riviere, M., Voštiar, I., Vitaliti, A., Sóvágó, J., Caputo, A., Winblad, B. G., & Graf, A. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0108-3 · Cited by 164
Eckl-Dorna, J., & Batista, F. D. (2009) · Blood · doi:10.1182/blood-2008-10-185421 · Cited by 163
Innate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen
Link, A., Zabel, F., Schnetzler, Y., Titz, A., Brombacher, F., & Bachmann, M. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103312 · Cited by 162
Self-citationLong-term efficacy and safety of human papillomavirus vaccination
Vincenzo, R. D., Conte, C., Ricci, C., Scambia, G., & Capelli, G. (2014) · International Journal of Women s Health · doi:10.2147/ijwh.s50365 · Cited by 158
Harnessing Nanoparticles for Immunomodulation and Vaccines
Gomes, A., Mohsen, M., & Bachmann, M. (2017) · Vaccines · doi:10.3390/vaccines5010006 · Cited by 158
Self-citationSafety of Human Papillomavirus Vaccines: A Review
Macartney, K. K., Chiu, C., Georgousakis, M., & Brotherton, J. M. L. (2013) · Drug Safety · doi:10.1007/s40264-013-0039-5 · Cited by 152
Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
Speiser, D. E., Schwarz, K., Baumgaertner, P., Manolova, V., Devêvre, E., Sterry, W., Walden, P., Zippelius, A., Conzett, K. B., Senti, G., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181f1d614 · Cited by 146
Self-citationBessa, J., Köpf, M., & Bachmann, M. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903949 · Cited by 140
Self-citationHofmann, K. J., Cook, J. C., Joyce, J. G., et al. (1995) · Virology · doi:10.1006/viro.1995.1283 · Cited by 134
Peyret, H., Annick, G., Thuenemann, E. C., Blond, D., El-Turabi, A., Beales, L., Clarke, D. S., Gilbert, R. J. C., Fry, E. E., Stuart, D. I., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120751 · Cited by 128
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
Moorthy, V., & Ballou, W. R. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-312 · Cited by 125
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
Bejon, P., White, M. T., Olotu, A., Bojang, K., Lusingu, J., Salim, N., Otsyula, N., Agnandji, S. T., Asante, K. P., Owusu‐Agyei, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70005-7 · Cited by 117
Spohn, G., Guler, R., Johansen, P., Keller, I., Jacobs, M., Beck, M., Röhner, F., Bauer, M., Dietmeier, K., Kündig, T. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7450 · Cited by 110
Self-citationBoosting Immunity to Small Tumor-Associated Carbohydrates with Bacteriophage Qβ Capsids
Yin, Z., Comellas-Aragonès, M., Chowdhury, S., Bentley, P. A., Kaczanowska, K., BenMohamed, L., Gildersleeve, J. C., Finn, M. G., & Huang, X. (2013) · ACS Chemical Biology · doi:10.1021/cb400060x · Cited by 105
The RTS,S vaccine candidate for malaria
Regules, J. A., Cummings, J. F., & Ockenhouse, C. F. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.57 · Cited by 100
Olotu, A., Moris, P., Mwacharo, J. K., Vekemans, J., Kimani, D., Janssens, M., Kai, O. K., Jongert, E., Lievens, M., Leach, A. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025786 · Cited by 98
Walker, A., Skamel, C., & Nassal, M. (2011) · Scientific Reports · doi:10.1038/srep00005 · Cited by 94
Engineered Mutations Change the Structure and Stability of a Virus-Like Particle
Fiedler, J. D., Higginson, C. J., Hovlid, M. L., Kislukhin, A. A., Castillejos, A. G., Manzenrieder, F., Campbell, M. G., Voss, N. R., Potter, C. S., Carragher, B. O., et al. (2012) · Biomacromolecules · doi:10.1021/bm300590x · Cited by 92
Virus‐like particles induce robust human T‐helper cell responses
Braun, M., Jandus, C., Maurer, P., Hammann‐Haenni, A., Schwarz, K., Bachmann, M. F., Speiser, D. E., & Romero, P. J. (2011) · European Journal of Immunology · doi:10.1002/eji.201142064 · Cited by 88
Self-citationEvaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines
Zuckerman, J. N., Zuckerman, A. J., Symington, I. S., Du, W., Williams, A. H., Dickson, B., & Young, M. D. (2001) · Hepatology · doi:10.1053/jhep.2001.27564 · Cited by 86
Mohsen, M. O., Gomes, A. C., Cabral‐Miranda, G., Krueger, C. C., Leoratti, F. M. S., Stein, J. V., & Bachmann, M. F. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.031 · Cited by 86
Self-citationAssembly and Release of Hepatitis B VirusPreprint
Selzer, L., & Zlotnick, A. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021394 · Cited by 82
Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses
Bessa, J., Jegerlehner, A., Hinton, H. J., Pumpens, P., Saudan, P., Schneider, P., & Bachmann, M. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804004 · Cited by 72
Self-citationLow, J. G. H., Lee, L., Ooi, E. E., Ethirajulu, K., Yeo, P., Matter, A., Connolly, J. E., Skibinski, D. A. G., Saudan, P., Bachmann, M. F., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.011 · Cited by 71
Self-citationAtmar, R. L., Baehner, F., Cramer, J. P., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw259 · Cited by 64
Development of viral nanoparticles for efficient intracellular delivery
Wu, Z., Chen, K., Yıldız, İ., Dirksen, A., Fischer, R., Dawson, P. E., & Steinmetz, N. F. (2012) · Nanoscale · doi:10.1039/c2nr30366c · Cited by 61
CpG ODN enhances uptake of bacteria by mouse macrophages
Utaisincharoen, P., Kespichayawattana, W., Anuntagool, N., et al. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02107.x · Cited by 58
Gregson, A. L., Oliveira, G. A., Othoro, C., Calvo‐Calle, J. M., Thorton, G. B., Nardin, E. H., & Edelman, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001556 · Cited by 55
Peters, B. S., CHEINGSONG-POPOV, R., Callow, D., Foxall, R. B., Patou, G., Hodgkin, K., & Weber, J. N. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)92814-0 · Cited by 47
Gomes, A. C., Flace, A., Saudan, P., Zabel, F., Cabral‐Miranda, G., El-Turabi, A., Manolova, V., & Bachmann, M. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00226 · Cited by 45
Self-citationSkibinski, D. A. G., Hanson, B. J., Lin, Y.-F., von Messling, V., Jegerlehner, A., Tee, J. B. S., Chye, D. H., Wong, S. K. K., Ng, A. A. P., Lee, H. Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076571 · Cited by 31
Self-citationValero-Pacheco, N., Pérez-Toledo, M., Villasís-Keever, M. Á., Núñez-Valencia, A., Boscó-Gárate, I., Lozano-Dubernard, B., Puente, H. L., Espitia, C., Alpuche-Aranda, C. M., Bonifaz, L. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150146 · Cited by 28
Horowitz, E. D., Finn, M. G., & Asokan, A. (2012) · ACS Chemical Biology · doi:10.1021/cb3000265 · Cited by 27
Impact of Pre-Exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination
Lindesmith, L. C., Mallory, M. L., Jones, T., Richardson, C., Goodwin, R. R., Baehner, F., Mendelman, P. M., Bargatze, R. F., & Baric, R. S. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix045 · Cited by 20
Rostovtsev, V. V., Green, L. G., Fokin, V. V., & Sharpless, K. B. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020715)41:14<2596::aid-anie2596>3.0.co;2-4
Cited by
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Nooraei, S., Bahrulolum, H., Hoseini, Z. S., Katalani, C., Hajizade, A., Easton, A. J., & Ahmadian, G. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00806-7 · Cited by 869
Mucosal vaccines — fortifying the frontiers
Lavelle, E. C., & Ward, R. W. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00583-2 · Cited by 752
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Liu, J., Fu, M., Wang, M., Wan, D., Wei, Y., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01247-x · Cited by 715
COVID-19 vaccine development and a potential nanomaterial path forward
Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., Wirth, D. M., Chen, A., Sack, M., Pokorski, J. K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0737-y · Cited by 659
Metadata
- Authors
- Mohsen, M. O., Zha, L., Cabral-Miranda, G., & Bachmann, M. F.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 34
- Pages
- 123-132
- ISSN
- 1044-5323 (ISSN-L)
- OpenAlex
- W2753483322
- Cited by
- 555
- References
- 77
- FWCI
- 14.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.